Shaokui Chen

Dr. Shaokui Chen


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JLJiahao Liu
Jiahao Liu
MZMohan Zhou
Mohan Zhou
QXQilong Xu
Qilong Xu
QLQingqing Lv
Qingqing Lv
JGJunjie Guo
Junjie Guo
YLYulan Liu
Yulan Liu
Quercetin (Que) is a flavonol compound found in plants, which has a variety of biological activities. Necroptosis, a special form of programmed cell death, plays a vital role in the development of many gastrointestinal diseases. This study aimed to explore whether Que could attenuate the intestinal injury and barrier dysfunction of piglets after deoxynivalenol (DON) exposure through modulating the necroptosis signaling pathway. Firstly, twenty-four weaned piglets were used in a 2 × 2 factorial design and the main factors, including Que (basal diet or diet supplemented with 100 mg/kg Que) and DON exposure (control feed or feed contaminated with 4 mg/kg DON). After feeding for 21 d, piglets were killed for samples. Next, the intestinal porcine epithelial cell line (IPEC-1) was pretreated with or without Que (10 μmol/mL) in the presence or absence of a DON challenge (0.5 μg/mL). Dietary Que increased the body weight, average daily gain, and average daily feed intake (p < 0.05) through the trial. Que supplementation improved the villus height, and enhanced the intestinal barrier function (p < 0.05) indicated by the higher protein expression of occludin and claudin-1 (p < 0.05) in the jejunum of the weaned piglets after DON exposure. Dietary Que also down-regulated the protein abundance of total receptor interacting protein kinase 1 (t-RIP1), phosphorylated RIP1 (p-RIP1), p-RIP3, total mixed lineage kinase domain-like protein (t-MLKL), and p-MLKL (p < 0.05) in piglets after DON exposure. Moreover, Que pretreatment increased the cell viability and decreased the lactate dehydrogenase (LDH) activity (p < 0.05) in the supernatant of IPEC-1 cells after DON challenge. Que treatment also improved the epithelial barrier function indicated by a higher transepithelial electrical resistance (TEER) (p < 0.001), lower fluorescein isothiocyanate-labeled dextran (FD4) flux (p < 0.001), and better distribution of occludin and claudin-1 (p < 0.05) after DON challenge. Additionally, pretreatment with Que also inhibited the protein abundance of t-RIP1, p-RIP1, t-RIP3, p-RIP3, t-MLKL, and p-MLKL (p < 0.05) in IPEC-1 cells after DON challenge. In general, our data suggest that Que can ameliorate DON-induced intestinal injury and barrier dysfunction associated with suppressing the necroptosis signaling pathway.

Verified
Journal Article
Open access
PDF file
JGJunjie Guo
Junjie Guo
XQXu Qin
Xu Qin
YWYang Wang
Yang Wang
XLXiangen Li
Xiangen Li
XWXiuying Wang
Xiuying Wang
YLYulan Liu
Yulan Liu
Necroptosis, an actively researched form of programmed cell death closely related to the inflammatory response, is important in a variety of disorders and diseases. However, the relationship between necroptosis and muscle protein degradation in cachexia is rarely reported. This study aimed to elucidate whether necroptosis played a crucial role in muscle protein degradation in a cachexia model of weaned piglets induced by lipopolysaccharide (LPS). In Experiment 1, the piglets were intraperitoneally injected with LPS to construct the cachexia model, and sacrificed at different time points after LPS injection (1, 2, 4, 8, 12, and 24 h). In Experiment 2, necrostatin-1 (Nec-1), a necroptosis blocker, was pretreated in piglets before the injection of LPS to inhibit the occurrence of necroptosis. Blood and longissimus dorsi muscle samples were collected for further analysis. In the piglet model with LPS-induced cachexia, the morphological and ultrastructural damage, and the release of pro-inflammatory cytokines including tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 were dynamically elicited in longissimus dorsi muscle. Further, protein concentration and protein/DNA ratio were dynamically decreased, and protein degradation signaling pathway, containing serine/threonine kinase (Akt), Forkhead box O (FOXO), muscular atrophy F-box (MAFbx), and muscle ring finger protein 1 (MuRF1), was dynamically activated in piglets after LPS challenge. Moreover, mRNA and protein expression of necroptosis signals including receptor-interacting protein kinase (RIP)1, RIP3, and mixed lineage kinase domain-like pseudokinase (MLKL), were time-independently upregulated. Subsequently, when Nec-1 was used to inhibit necroptosis, the morphological damage, the increase in expression of pro-inflammatory cytokines, the reduction in protein content and protein/DNA ratio, and the activation of the protein degradation signaling pathway were alleviated. These results provide the first evidence that necroptosis mediates muscle protein degradation in cachexia by LPS challenge.

15 November 2024 in International Immunopharmacology
Verified
Journal Article
Closed access
XQXu Qin
Xu Qin
XLXiaotong Li
Xiaotong Li
JGJunjie Guo
Junjie Guo
MZMohan Zhou
Mohan Zhou
QXQilong Xu
Qilong Xu
SCShaokui Chen
Shaokui Chen

17 April 2026 in Animals
Verified
Journal Article
Open access
PDF file
JLJiasi Liu
Jiasi Liu
MZMinfang Zhang
Minfang Zhang
MZMohan Zhou
Mohan Zhou
JGJunjie Guo
Junjie Guo
SCShaokui Chen
Shaokui Chen
YLYulan Liu
Yulan Liu
Fish oil (FO) has been shown to confer beneficial effects on hepatic diseases in both humans and animals. This study aimed to investigate whether dietary fish oil (FO) supplementation alleviates deoxynivalenol (DON)-induced liver injury by modulating the ferroptosis signaling pathway in weaned piglets. Twenty-four weaned piglets were allocated to a 2 × 2 factorial design, with the main factors consisting of dietary treatment (5% corn oil or 5% FO supplementation) and DON exposure (basal diet or diet contaminated with 4 mg/kg DON). After 21 days of dietary treatment, piglets were euthanized for collection of blood and liver samples. Dietary FO significantly attenuated DON-induced hepatic structural damage and inflammatory infiltration. Specifically, FO supplementation reduced the activities of aspartate transaminase (AST) and alkaline phosphatase (ALP), as well as the AST/alanine aminotransferase (ALT) ratio following DON exposure. Dietary FO also decreased malondialdehyde (MDA) concentrations in both the liver and serum, lowered hepatic 4-hydroxynonenal (4-HNE) level and Fe2+ content, and increased hepatic glutathione (GSH) content. Moreover, dietary FO ameliorated ultrastructural liver damage induced by DON. Furthermore, DON significantly downregulated the mRNA levels of multiple genes associated with iron metabolism and ferroptosis, including heat shock protein beta-1 (HSPB1), acyl-CoA synthetase long chain family member 4 (ACSL4), and arachidonate 15-lipoxygenase (ALOX15), and upregulated the mRNA levels of transferrin (TF), ferritin heavy chain (FTH), solute carrier family 7 member 11 (SLC7A11), and transferrin receptor 1 (TFR1). Dietary FO counteracted these alterations by decreasing the mRNA of SLC7A11, TFR1, FTH, and TF after DON exposure. Finally, FO significantly decreased the protein expression of SLC7A11, iron-responsive element-binding protein 2 (IREB2), and FHT1 and increased the GPX4 protein expression following DON exposure. These findings suggest that FO may ameliorate DON-induced liver injury in weaned piglets, possibly through suppressing the ferroptosis signaling pathway.

14 February 2026 in Biology
Verified
Journal Article
Open access
PDF file
KSKui Shu
Kui Shu
JXJuan Xiong
Juan Xiong
XXXianfeng Xu
Xianfeng Xu
YDYuelong Deng
Yuelong Deng
Kan XiaoKan Xiao
Kan Xiao
SCShaokui Chen
Shaokui Chen
Macrophage polarization is widely recognized as a pivotal role in the maintenance of liver homeostasis. Lysolecithin (LPC) has previously been associated with hepatoprotective effect. This study aimed to determine whether LPC protected against lipopolysaccharide (LPS)-induced liver injury by modulating macrophage polarization. Twenty-four piglets were allocated in a 2 × 2 factorial design, involving dietary supplementation (0 vs. 0.01% LPC) and immunological challenge (saline vs. LPS). Animals were euthanized 4 h post-injection, and liver tissues were harvested for analysis. Our findings showed that LPS challenge induced significant liver damage, which was ameliorated by LPC supplementation, as evidenced by improved histological and functional outcomes. LPC counteracted the LPS-induced dysregulation of mRNA expression related to macrophage polarization, including pro-inflammatory markers (IL-6, IL-1β, TNF-α, IFN-γ, iNOS, and CD80) (p < 0.05). Furthermore, LPC restored the expression of key metabolic genes involved in glycolysis and the TCA cycle (HK2 and IDH) (p < 0.05). Mechanistically, LPC normalized the activation of the mTOR signaling pathway by modulating both mRNA and protein levels of mTOR, S6K1, and HIF-1α (p < 0.05). These findings suggest that LPC attenuates LPS-induced liver injury by influencing metabolic and inflammatory pathways, potentially through the inhibiting M1 polarization mediated by glycolysis-related mTOR signaling pathways. Targeting macrophage polarization by LPC may represent a promising therapeutic strategy for inflammatory liver conditions.